High-throughput immunoassays for SARS-CoV-2 - considerable differences in performance when comparing three methods.

Ekelund, Oskar; Ekblom, Kim; Somajo, Sofia; Pattison-Granberg, Johanna; Olsson, Karl; Petersson, Annika

Ekelund, Oskar; Ekblom, Kim; Somajo, Sofia; Pattison-Granberg, Johanna; Olsson, Karl; Petersson, Annika.

Afiliação

Ekelund O; Department of Clinical Microbiology, Växjö Central Hospital, Växjö, Sweden.
Ekblom K; Department of Clinical Microbiology, Blekinge County Hospital, Karlskrona, Sweden.
Somajo S; Department of Clinical Chemistry and Transfusion Medicine, Växjö Central Hospital, Växjö, Sweden.
Pattison-Granberg J; Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.
Olsson K; Department of Clinical Microbiology, Blekinge County Hospital, Karlskrona, Sweden.
Petersson A; Department of Clinical Chemistry and Transfusion Medicine, Växjö Central Hospital, Växjö, Sweden.

Infect Dis (Lond) ; 53(10): 805-810, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34053400

Assuntos

COVID-19; SARS-CoV-2; Anticorpos Antivirais; Humanos; Imunoensaio; Pandemias; Sensibilidade e Especificidade

Palavras-chave

COVID-19; SARS-CoV-2; antibodies; immunology; serology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Infect Dis (Lond) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google